Outcomes for Patients with Pre-Existing Diabetes or Hypertension Treated with Copanlisib from the CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma

被引：0

作者：

Zinzani, Pier Luigi ^{[1
]}

Santoro, Armando ^{[2
]}

Mollica, Luigina ^{[3
]}

Leppa, Sirpa ^{[4
]}

Follows, George A. ^{[5
]}

Lenz, Georg ^{[6
]}

Kim, Won Seog ^{[7
]}

Nagler, Arnon ^{[8
]}

Panayiotidis, Panayiotis ^{[9
]}

Demeter, Judit ^{[10
]}

Morschhauser, Franck ^{[11
]}

Rodrigues, Liana ^{[12
]}

Reeves, John ^{[13
]}

Hiemeyer, Florian ^{[14
]}

Miriyala, Ashok ^{[15
]}

Garcia-Vargas, Jose ^{[15
]}

Childs, Barrett H. ^{[15
]}

Dreyling, Martin H. ^{[16
]}

机构：

[1] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy

[2] IRCCS Humanitas Inst, Med Oncol, Milan, Italy

[3] Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada

[4] Univ Helsinki, Hosp Canc Ctr, Helsinki, Finland

[5] Cambridge Univ Hosp NHS Trust, Cambridge, England

[6] Univ Hosp Munster, Translat Oncol, Munster, Germany

[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[8] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Hashomer, Israel

[9] Univ Athens, Sch Med, Athens, Greece

[10] Semmelweis Univ, Budapest, Hungary

[11] CHRU, Hop Claude Huriez, Lille, France

[12] Bayer SA, Sao Paulo, Brazil

[13] Joule INC, Edison, NJ USA

[14] Bayer AG, Pharmaceut Div, Berlin, Germany

[15] Bayer HealthCare Pharmaceut, Whippany, NJ USA

[16] Klinikum Univ Munchen Grosshadern, Med Klin & Poliklin 3, Munich, Germany

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-117063

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1613

引用

下载

页数：4

共 50 条

[1] Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Dimou, Maria
Demeter, Judit
Magagnoli, Massimo
Rodrigues, Liana
Wirtz, Oliver
Hiemeyer, Florian
Liu, Li
Koechert, Karl
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
Dreyling, Martin H.
BLOOD, 2018, 132
[2] Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses from the CHRONOS-1 study
Provencio Pulla, M.
Santoro, A.
Mollica, L.
Leppa, S.
Follows, G.
Lenz, G.
Kim, W. S.
Nagler, A.
Panayiotidis, P.
Demeter, J.
Ozcan, M.
Kosinova, M.
Bouabdallah, K.
Morschhauser, F.
Ishida, T.
Huang, L.
Garcia-Vargas, J.
Childs, B. H.
Zinzani, P. L.
Dreyling, M.
ANNALS OF ONCOLOGY, 2017, 28
[3] Copanlisib in patients with relapsed or refractory indolent B-cell lymphoma: Primary results of the pivotal Chronos-1 study
Dreyling, Martin
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit
Ozcan, Muhit
Kosinova, Marina
Bouabdallah, Krimo
Morschhauser, Franck
Stevens, Don A.
Trevarthen, David
Giurescu, Marius
Kupit, Lisa
Yin, Shuxin
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
CANCER RESEARCH, 2017, 77
[4] Copanlisib (COP) in patients with relapsed or refractory indolent B-cell lymphoma: primary results of the pivotal Chronos-1 study
Dreyling, M.
Santoro, A.
Mollica, L.
Leppa, S.
Follows, G. A.
Lenz, G.
Kim, W. S.
Nagler, A.
Panayiotidis, P.
Demeter, J.
Ozcan, M.
Kosinova, M.
Bouabdallah, K.
Morschhauser, F.
Stevens, D. A.
Trevarthen, D.
Giurescu, M.
Kupit, L.
Childs, B. H.
Zinzani, P. L.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 12 - 12
[5] Long-Term Efficacy and Safety from the Copanlisib CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma
Dreyling, Martin
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit
Ozcan, Muhit
Kosinova, Marina
Bouabdallah, Krimo
Morschhauser, Franck
Stevens, Don
Trevarthen, David
Rodrigues, Liana
Hiemeyer, Florian
Wang, MingLu
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
BLOOD, 2018, 132
[6] Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses of diabetic patients from the phase II CHRONOS-1 study.
Dreyling, Martin H.
Leppa, Sirpa
Comeau, Terrance
Kosinova, Marina
Lenz, Georg
Nagler, Arnon
Heo, Dae Seog
Oh, Sung Yong
Huang, Liping
Wirtz, Oliver
Miriyala, Ashok
Garcia-Vargas, Jose E.
Childs, Barrett H.
Zinzani, Pier Luigi
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[7] EFFICACY AND SAFETY OF COPANLISIB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE CHRONOS-1 STUDY
Zinzani, P. L.
Santoro, A.
Leppa, S.
Demeter, J.
Follows, G. A.
Lenz, G.
Kim, W. S.
Mollica, L.
Nagler, A.
Diong, C. P.
Provenciio, M.
Stevens, D. A.
Trevarthen, D.
Maagnoli, M.
Cupit, L.
Yin, S.
Hiemeyer, F.
Garcia-Vargas, J.
Childs, B. H.
Dreyling, M.
HAEMATOLOGICA, 2017, 102 : 314 - 315
[8] Updated Safety and Efficacy from the Copanlisib CHRONOS-1 Trial in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma: Low Incidence of Late-Onset Severe Toxicities
Dreyling, Martin
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit
Ozcan, Muhit
Kosinova, Marina
Bouabdallah, Krimo
Morschhauser, Franck
Stevens, Don A.
Trevarthen, David
Magagnoli, Massimo
Ishida, Tatiane
Lu, Cindy
Hiemeyer, Florian
Miriyala, Ashok
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
BLOOD, 2017, 130
[9] Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial
Dreyling, Martin
Panayiotidis, Panayiotis
Egyed, Miklos
Follows, George
Mollica, Luigina
Nagler, Arnon
Ozcan, Muhit
Santoro, Armando
Ishida, Tatiane
Lu, Cindy
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
BLOOD, 2017, 130
[10] Efficacy of Copanlisib Monotherapy in Patients With Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis From the CHRONOS-1 Trial
Martin, Peter
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 10 - 11

← 1 2 3 4 5 →